214 related articles for article (PubMed ID: 1833569)
21. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
[No Abstract] [Full Text] [Related]
22. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
24. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
25. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
26. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
27. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
28. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
30. [Alpha 2plasmin-inhibitor . plasmin complex (PIC)--useful diagnostic and prognostic parameter].
Taniguchi T; Matsuo T; Hishikawa R; Yamaguchi A; Akato S; Shibatouge M
Rinsho Byori; 1991 Jul; 39(7):714-9. PubMed ID: 1833570
[TBL] [Abstract][Full Text] [Related]
31. Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Henriksson AE; Nilsson TK; Jansson U; Bergqvist D
Thromb Res; 1996 Jun; 82(5):409-15. PubMed ID: 8771701
[TBL] [Abstract][Full Text] [Related]
32. Dysfunctional antithrombin III in sick premature infants.
Andrew M; Massicotte-Nolan P; Mitchell L; Cassidy K
Pediatr Res; 1985 Feb; 19(2):237-9. PubMed ID: 3982886
[TBL] [Abstract][Full Text] [Related]
33. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
34. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
35. Thrombin inhibition is impaired in plasma of sick neonates.
Shah JK; Mitchell LG; Paes B; Ofosu FA; Schmidt B; Andrew M
Pediatr Res; 1992 Apr; 31(4 Pt 1):391-5. PubMed ID: 1373886
[TBL] [Abstract][Full Text] [Related]
36. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
[TBL] [Abstract][Full Text] [Related]
37. Significance of glomerular deposition of plasmin-alpha 2-plasmin inhibitor complexes in various glomerulopathies.
Suzuki S; Sato H; Shimada H; Takashima N; Kishimoto H; Ueno M; Nishi S; Wada K; Takahashi H; Shibata A
Clin Nephrol; 1993 Nov; 40(5):270-6. PubMed ID: 7506640
[TBL] [Abstract][Full Text] [Related]
38. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer.
Taguchi O; Gabazza EC; Yoshida M; Yamakami T; Kobayashi H; Shima T
Clin Chim Acta; 1996 Jan; 244(1):69-81. PubMed ID: 8919202
[TBL] [Abstract][Full Text] [Related]
39. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
40. Development of a latex immunoturbidimetric assay for the automated measurement of alpha2 plasmin inhibitor-plasmin complex in human plasma.
Fujimoto T; Nakamura K; Nishihira J
Semin Thromb Hemost; 1999; 25(6):551-6. PubMed ID: 10632477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
